| Filed On | Filing |
|---|---|
| 22 May 2026 | F-6 POS |
| 21 May 2026 | 424B3 |
| 21 May 2026 | 15F-12B |
| 11 May 2026 | 25 |
| 11 May 2026 | SCHEDULE 13G/A |
| 06 May 2026 |
Form 4: PureTech Health plc, 10% owner and 1 other · Seaport Therapeutics Inc
Received 16,382,534 shares by conversion |
| 01 May 2026 | 6-K |
| 30 Apr 2026 |
Form 3: PureTech Health plc, 10% owner and 1 other · Seaport Therapeutics Inc
Holds 302,479 shares of Common Stock |
| 29 Apr 2026 | SCHEDULE 13G |
| 29 Apr 2026 | 20-F |
| 29 Apr 2026 | 6-K |
| 29 Apr 2026 | 6-K |
| 18 Dec 2025 | 6-K |
| 10 Dec 2025 | 6-K |
| 28 Aug 2025 | 6-K |
| 11 Aug 2025 | SCHEDULE 13G |
| 16 Jul 2025 | 6-K |
| 08 Jul 2025 | 6-K |
| 16 Jun 2025 | 6-K |
| 30 Apr 2025 | 6-K |
Loading...
